117 related articles for article (PubMed ID: 9045054)
21. [Li-Fraumeni syndrome].
Alonso-Cerezo MC; Pérez-Pérez P
Med Clin (Barc); 2011 Oct; 137(9):425-6. PubMed ID: 21345471
[No Abstract] [Full Text] [Related]
22. [Tumor suppressor gen mutation in the germ line: its significance in familial and sporadic tumors].
Müller H; Scott RJ
Schweiz Med Wochenschr; 1995 Jul; 125(30):1445-54. PubMed ID: 7676234
[TBL] [Abstract][Full Text] [Related]
23. Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree.
Fernández-Martínez L; Villegas JA; Santamaría Í; Pitiot AS; Alvarado MG; Fernández S; Torres H; Paredes Á; Blay P; Balbín M
BMC Cancer; 2017 Feb; 17(1):146. PubMed ID: 28222777
[TBL] [Abstract][Full Text] [Related]
24. The p53 tumor-suppressor gene.
Levine AJ
N Engl J Med; 1992 May; 326(20):1350-2. PubMed ID: 1565147
[No Abstract] [Full Text] [Related]
25. Molecular pathogenesis of bilateral breast cancer.
Imyanitov EN; Hanson KP
Cancer Lett; 2003 Feb; 191(1):1-7. PubMed ID: 12609703
[TBL] [Abstract][Full Text] [Related]
26. Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.
Schulz E; Valentin A; Ulz P; Beham-Schmid C; Lind K; Rupp V; Lackner H; Wölfler A; Zebisch A; Olipitz W; Geigl J; Berghold A; Speicher MR; Sill H
J Med Genet; 2012 Jul; 49(7):422-8. PubMed ID: 22652532
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetics and management strategies in hereditary cancer syndromes.
Hanna NN; Mentzer RM
J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901
[TBL] [Abstract][Full Text] [Related]
28. Overexpression or mutation of the p53 tumor suppressor gene does not occur in malignant ovarian germ cell tumors.
Liu FS; Ho ES; Chen JT; Shih RT; Yang CH; Shih A
Cancer; 1995 Jul; 76(2):291-5. PubMed ID: 8625105
[TBL] [Abstract][Full Text] [Related]
29. Absence of p53 germ-line mutations in bilateral breast cancer patients.
Lidereau R; Soussi T
Hum Genet; 1992 May; 89(2):250-2. PubMed ID: 1587536
[TBL] [Abstract][Full Text] [Related]
30. A novel familial germline mutation in the initiator codon of the BHD gene in a patient with Birt-Hogg-Dubé syndrome.
Bessis D; Giraud S; Richard S
Br J Dermatol; 2006 Nov; 155(5):1067-9. PubMed ID: 17034545
[No Abstract] [Full Text] [Related]
31. The p53 tumour suppressor gene.
Levine AJ; Momand J; Finlay CA
Nature; 1991 Jun; 351(6326):453-6. PubMed ID: 2046748
[TBL] [Abstract][Full Text] [Related]
32. Cancer risks from germ line tumor suppressor gene mutations.
Frebourg T; Malkin D; Friend S
Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
[TBL] [Abstract][Full Text] [Related]
33. A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.
Felix CA; Strauss EA; D'Amico D; Tsokos M; Winter S; Mitsudomi T; Nau MM; Brown DL; Leahey AM; Horowitz ME
Oncogene; 1993 May; 8(5):1203-10. PubMed ID: 8479743
[TBL] [Abstract][Full Text] [Related]
34. p53 tumor suppressor gene: implications for iatrogenic cancer and cancer therapy.
De Benedetti V; Bennett WP; Greenblatt MS; Harris CC
Med Pediatr Oncol Suppl; 1996; 1():2-11. PubMed ID: 8643042
[No Abstract] [Full Text] [Related]
35. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of families with aggregation of lung cancer.
Tomizawa Y; Adachi J; Kohno T; Yamaguchi N; Saito R; Yokota J
Jpn J Clin Oncol; 1998 Mar; 28(3):192-5. PubMed ID: 9614442
[TBL] [Abstract][Full Text] [Related]
37. Second tumours.
Meadows AT
Eur J Cancer; 2001 Nov; 37(16):2074-9; discussion 2079-81. PubMed ID: 11597387
[No Abstract] [Full Text] [Related]
38. Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
Zweemer RP; Shaw PA; Verheijen RM; Ryan A; Berchuck A; Ponder BA; Risch H; McLaughlin JR; Narod SA; Menko FH; Kenemans P; Jacobs IJ
J Clin Pathol; 1999 May; 52(5):372-5. PubMed ID: 10560359
[TBL] [Abstract][Full Text] [Related]
39. Increased general predisposition to cancer but not to specific neoplasms of the hematopoietic system in children with hematological neoplasms: a hypothesis.
Roganovic J; Radojcic-Badovinac A
Acta Haematol; 2000; 103(3):172-4. PubMed ID: 10940658
[No Abstract] [Full Text] [Related]
40. Paraganglioma syndrome and mutations of the SDHC gene.
Niemann S
JAMA; 2006 Feb; 295(6):625; author reply 625. PubMed ID: 16467230
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
